-
Health todayCancer new
Menopausal hormone therapy users had higher breast cancer incidence but lower mortality
In 78,209 women in the PLCO screening trial, ever use of menopausal hormone therapy was associated with higher breast cancer incidence (aHR 1.17) and lower breast cancer mortality (0.72).
Preprint · not peer-reviewed -
Data, models and systemsValue in health new
Modelled extra HPV doses for women with HIV averted cervical cancer
A Markov model of 13 African countries found that extra HPV doses for women living with HIV averted cervical cancer beyond routine vaccination at 14, at added programme cost.
Preprint · not peer-reviewed -
Health todayCancer refines
Under 2 mm of Gleason pattern 4 matches favourable intermediate-risk prostate cancer
Among 2499 men with Grade Group 2-4 prostate cancer, those with under 2 mm of Gleason pattern 4 had 5-year biochemical recurrence of 20%, matching favourable intermediate-risk disease.
Peer-reviewed -
Health todayCancer new
PSMA-guided radiotherapy did not improve failure-free survival in prostate cancer
In a phase 2 trial of 253 men, radiotherapy targeted to every lesion seen on PSMA-PET gave five-year failure-free survival of 66% against 62% for standard care.
Peer-reviewed -
Health todayCancer confirms
Multi-cancer early detection blood test detected 15.4% of stage I cancers
A methylation and protein blood test identified 50.9% of cancers across 21 tumour organ types at a specificity of 98.5%, in a multi-centre case-control study of 6,352 samples.
Peer-reviewed -
Data, models and systemsForecasts and their record new
Nigeria's HPV programme is modelled to avert 1.82 million cervical cancers
Continuing to vaccinate Nigerian girls aged 9 to 14 is projected to avert 1.82 million cervical cancer cases to 2100, with 945,000 remaining in women already too old.
Preprint · not peer-reviewed -
Health todayCancer refines
England's cervical screening coverage gap by deprivation has widened to 7.4 points
Cervical screening coverage in England in 2024 ranged from 73.5% in the least deprived areas to 66.1% in the most deprived, a wider gap than that recorded twelve years earlier.
Peer-reviewed -
Tomorrow's worldA changing climate new
Daily cancer deaths in Japan were 0.88% higher per 10 micrograms/m3 of PM2.5
A 10 microgram per cubic metre rise in PM2.5 was associated with 0.88% more cancer deaths in Japan, though the association did not survive adjustment for NO2 or SO2.
Peer-reviewed -
Behavioural scienceInfection and pandemics new
Offering HPV vaccine at 9-10 brought median series completion to 12.2 years
In a cluster-randomised trial in 31 US paediatric practices, offering HPV vaccination at ages 9-10 rather than 11-12 brought median age at series completion forward from 13.3 to 12.2 years.
Preprint · not peer-reviewed -
Behavioural scienceAdherence and persistence refines
Seven in ten US women stay on endocrine therapy for one year
Of 401,450 US women starting adjuvant endocrine therapy after breast surgery, 69.9% had a medication possession ratio of at least 80% over the first year.
Preprint · not peer-reviewed -
Health todayCancer new
Myelosuppression is gemcitabine's most consistent signal in FDA adverse event reports
In 18.37 million adverse event reports made to the FDA since 2014, myelosuppression was reported 3.35 to 7.74 times more often with gemcitabine regimens than with other drugs.
Preprint · not peer-reviewed -
Health todayCancer new
Blood-based multicancer screening did not reduce late-stage cancer in 142,250 adults
In the NHS-Galleri trial of 142,250 adults in England, three annual rounds of multicancer early-detection testing did not reduce stage III or IV cancer incidence (rate ratio 1.03).
Peer-reviewed